200 related articles for article (PubMed ID: 876531)
1. Combination chemotherapy of advanced endometrial adenocarcinoma with adriamycin, cyclophosphamide, 5-fluorouracil, and medroxyprogesterone acetate.
Bruckner HW; Deppe G
Obstet Gynecol; 1977 Jul; 50(1 Suppl):10s-12s. PubMed ID: 876531
[TBL] [Abstract][Full Text] [Related]
2. Treatment of advanced adenocarcinoma of the endometrium with melphalan, 5-fluorouracil, and medroxyprogesterone acetate: a preliminary study.
Cohen CJ; Deppe G; Bruckner HW
Obstet Gynecol; 1977 Oct; 50(4):415-7. PubMed ID: 904803
[TBL] [Abstract][Full Text] [Related]
3. Doxorubicin and cyclophosphamide chemotherapy for disseminated endometrial cancer.
Seski JC; Edwards CL; Gershenson DM; Copeland LJ
Obstet Gynecol; 1981 Jul; 58(1):88-91. PubMed ID: 7195533
[TBL] [Abstract][Full Text] [Related]
4. Use of cisplatin, doxorubicin, and cyclophosphamide to treat advanced and recurrent adenocarcinoma of the endometrium.
Hancock KC; Freedman RS; Edwards CL; Rutledge FN
Cancer Treat Rep; 1986 Jun; 70(6):789-91. PubMed ID: 3731140
[TBL] [Abstract][Full Text] [Related]
5. Treatment of advanced or recurrent endometrial adenocarcinoma with cyclophosphamide, doxorubicin, cis-Platinum, and megestrol acetate.
Lovecchio JL; Averette HE; Lichtinger M; Townsend PA; Girtanner RW; Fenton AN
Obstet Gynecol; 1984 Apr; 63(4):557-60. PubMed ID: 6538327
[TBL] [Abstract][Full Text] [Related]
6. [Therapy of advanced endometrial cancer].
Okada H; Yamamoto T
Gan To Kagaku Ryoho; 1990 Sep; 17(9):1848-55. PubMed ID: 2144105
[TBL] [Abstract][Full Text] [Related]
7. Comparison of adriamycin with cyclophosphamide in patients with advanced endometrial cancer.
Horton J; Begg CB; Arseneault J; Bruckner H; Creech R; Hahn RG
Cancer Treat Rep; 1978 Jan; 62(1):159-61. PubMed ID: 626996
[No Abstract] [Full Text] [Related]
8. Monochemotherapy (Adriamycin) for metastatic breast cancer in progression after sequential hormone-chemotherapy (MAP and CMF). Pilot study.
Pannuti F; Rossi AP; Di Marco AR; Fruet F; Lelli G; Strocchi E; Rocchetta G; Piana E; Martoni A
Panminerva Med; 1981; 23(1):25-8. PubMed ID: 7290722
[No Abstract] [Full Text] [Related]
9. [Chemo-(hormonal)-therapy of advanced ovarian neoplasms in FIGO stages III and IV. Prospective SAKK-study 20/71].
Senn HJ; Lei D; Castaño-Almendral A; Brunner KW; Martz G; Obrecht P; Melchert F; Rhomberg W
Schweiz Med Wochenschr; 1980 Aug; 110(33):1202-8. PubMed ID: 7423163
[TBL] [Abstract][Full Text] [Related]
10. [Combination chemotherapy using cyclophosphamide, adriamycin, and cisplatin in recurrent or advanced endometrial cancer--a preliminary report].
Baba S; Kashimura M; Shinohara M; Kusano S; Sasayama T; Hamasaki K
Gan No Rinsho; 1989 Feb; 35(3):371-7. PubMed ID: 2926985
[TBL] [Abstract][Full Text] [Related]
11. Combination chemotherapy for advanced endometrial adenocarcinoma.
Deppe G; Bruckner HW; Cohen CJ
Int J Gynaecol Obstet; 1980; 18(3):168-9. PubMed ID: 6109646
[TBL] [Abstract][Full Text] [Related]
12. Melphalan, 5-fluorouracil, and medroxyprogesterone acetate in metastatic or recurrent endometrial carcinoma. Preliminary report.
Piver MS; Lele S; Barlow JJ
Obstet Gynecol; 1980 Sep; 56(3):370-2. PubMed ID: 7422177
[TBL] [Abstract][Full Text] [Related]
13. Antitumor effect of combination of cyclophosphamide, adriamycin and platinum (CAP) versus cyclophosphamide, adriamycin and 5-fluorouracil (CAF) in metastatic breast cancer.
Tzekova V; Velikova M; Koynov K; Micheva D; Donchev T
Neoplasma; 1991; 38(6):603-7. PubMed ID: 1766485
[TBL] [Abstract][Full Text] [Related]
14. Chemo-hormonal therapy for metastatic renal cell carcinoma with adriamycin, hydroxyurea, vinblastine, and medroxyprogesterone acetate.
Katakkar SB; Franks CR
Cancer Treat Rep; 1978 Sep; 62(9):1379-80. PubMed ID: 688282
[TBL] [Abstract][Full Text] [Related]
15. A pilot study of sequential combination chemotherapy with adriamycin and cyclophosphamide, and methotrexate, 5-fluorouracil and prednisolone in advanced breast cancer.
Collis CH
Br J Clin Pract; 1978 May; 32(5):139-44. PubMed ID: 666968
[No Abstract] [Full Text] [Related]
16. Vaginal cytologic evaluation as a practical link between hormone blood levels and tumor hormone dependency in exclusive medroxyprogesterone treatment of recurrent or metastatic endometrial adenocarcinoma.
Bonte J; Decoster JM; Ide P
Acta Cytol; 1977; 21(2):218-24. PubMed ID: 266331
[TBL] [Abstract][Full Text] [Related]
17. Cytologic evaluation of exclusive medroxyprogesterone acetate treatment for vaginal recurrence of endometrial adenocarcinoma.
Bonte J; Drochmans A; Ide P
Acta Cytol; 1970 May; 14(5):353-6. PubMed ID: 5284269
[No Abstract] [Full Text] [Related]
18. [Combination chemotherapy of cyclophosphamide adriamycin and 5-fluorouracil (CAF) in advanced and recurrent breast cancer].
Abe O; Izuo M; Enomoto K; Kubo K; Koyama H; Sakai K; Terasawa T; Tominaga T; Nomura Y
Gan To Kagaku Ryoho; 1982 May; 9(5):866-73. PubMed ID: 7184431
[TBL] [Abstract][Full Text] [Related]
19. Multidrug treatment of advanced and recurrent endometrial carcinoma: a Gynecologic Oncology Group study.
Cohen CJ; Bruckner HW; Deppe G; Blessing JA; Homesley H; Lee JH; Watring W
Obstet Gynecol; 1984 May; 63(5):719-26. PubMed ID: 6371627
[TBL] [Abstract][Full Text] [Related]
20. Chemotherapy for metastatic carcinoid tumors: experiences with 32 patients and a review of the literature.
Legha SS; Valdivieso M; Nelson RS; Benjamin RS; Bodey GP
Cancer Treat Rep; 1977 Dec; 61(9):1699-703. PubMed ID: 597818
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
